Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.055 USD | +0.81% | +3.87% | +153.41% |
Apr. 10 | Arcutis Biotherapeutics, Inc. Announces Chief Financial Officer Changes | CI |
Mar. 18 | Arcutis Biotherapeutics, Inc.(NasdaqGS:ARQT) added to S&P Biotechnology Select Industry Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+153.41% | 923M | |
+4.81% | 111B | |
+12.06% | 105B | |
-12.61% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.59% | 16.96B | |
+4.19% | 13.7B | |
+37.08% | 12.45B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Aeglea BioTherapeutics Appoints Scott Burrows as CFO